Int J Med Sci 2020; 17(11):1625-1638. doi:10.7150/ijms.47103 This issue
Vitamin C: A Review on its Role in the Management of Metabolic Syndrome
Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia.
Wong SK, Chin KY, Ima-Nirwana S. Vitamin C: A Review on its Role in the Management of Metabolic Syndrome. Int J Med Sci 2020; 17(11):1625-1638. doi:10.7150/ijms.47103. Available from https://www.medsci.org/v17p1625.htm
Oxidative stress and inflammation are two interlinked events that exist simultaneously in metabolic syndrome (MetS) and its related complications. These pathophysiological processes can be easily triggered by each other. This review summarizes the current evidence from animal and human studies on the effects of vitamin C in managing MetS. In vivo studies showed promising effects of vitamin C, but most of the interventions used were in combination with other compounds. The direct effects of vitamin C remain to be elucidated. In humans, the current state of evidence revealed that lower vitamin C intake and circulating concentration were found in MetS subjects. A negative relationship was observed between vitamin C intake / concentration and the risk of MetS. Oral supplementation of vitamin C also improved MetS conditions. It has been postulated that the positive outcomes of vitamin C may be in part mediated through its anti-oxidative and anti-inflammatory properties. These observations suggest the importance of MetS patients to have an adequate intake of vitamin C through food, beverages or supplements in order to maintain its concentration in the systemic circulation and potentially reverse MetS.
Keywords: antioxidants, ascorbic acid, ascorbate, inflammation, oxidative stress.
The harmonised criteria according to Joint Interim Statement define metabolic syndrome (MetS) in the presence of at least three out of these five metabolic abnormalities: elevated waist circumference, blood pressure (BP), fasting blood glucose (FBG), triglycerides (TG) and reduced high-density lipoprotein cholesterol (HDL-C) . The unhealthy dietary pattern, such as high consumption of refined carbohydrate and saturated fat, is directly correlated with MetS development [2-5]. The lack of moderate-to-vigorous physical activity is also one of the important risk factors for MetS . MetS patients are advised to adopt lifestyle-based interventions as the initial management, such as avoiding food and beverage containing high sugar and fat content along with maintaining aerobic exercise. Drug therapies (medications for obesity, hyperglycaemia, hypertension and hypercholesterolemia) and bariatric surgery are recommended if lifestyle modifications are not successful in improving MetS conditions.
Recently, there is a growing interest in employing anti-oxidative and anti-inflammatory agents as prophylactic or therapeutic agents against MetS [7-10], in line with the speculation that oxidative stress and inflammation play a significant role in the pathophysiology of MetS. Under this hypothesis, oxidative damage and inflammation are triggered by exogenous factors, like an overabundance of dietary carbohydrate and lipid. Dietary fat mainly consists of a combination of saturated fatty acid (SFA), trans-unsaturated fatty acid (TFA), monounsaturated fatty acid (MUFA) and polyunsaturated fatty acid (PUFA) with different health effects . The degree of saturation in dietary fat has been proposed to differentially influence the several key factors of MetS. Both SFA and TFA are highly atherogenic by increasing the levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol (VLDL-C), apolipoprotein A-1 (apoA1) and decreasing the level of HDL-C. In contrast, MUFA and PUFA have favourable effects on atherogenicity by reducing TC, LDL-C and elevating HDL-C . Excessive macronutrients ingestion generates a large amount of reactive oxygen species (ROS) as by-product causing lipid peroxidation and oxidative stress that eventually lead to inflammation via activation of nuclear factor-kappa B (NF-κB) signalling pathway [12,13]. Likewise, the increase in adipocyte size and number arise from abdominal obesity and dyslipidaemia elevate the endogenous pool of pro-inflammatory cytokines, which act as potent stimulators for ROS production by macrophages and monocytes . Therefore, the interdependence of oxidative stress and inflammation suggests the potential use of agents exhibiting anti-oxidative and anti-inflammatory activities simultaneously to mitigate MetS.
Vitamin C, known as ascorbic acid or ascorbate, is an essential water-soluble micronutrient traditionally used to prevent and treat scurvy. Vitamin C is present universally in both plants and animals. The major dietary sources of vitamin C are fresh fruits and vegetables. Vitamin C has been suggested to be beneficial in reversing MetS-associated abnormalities based on several considerations. Plasma vitamin C concentration was inversely associated with body mass index (BMI), percentage of body fat and waist circumference . Vitamin C supplementation resulted in significant decreases in blood glucose , BP , TG and LDL-C . Moreover, vitamin C is a powerful antioxidant because it acts as a reducing agent preventing other compounds from being oxidised. By donating electrons, vitamin C scavenges harmful free radicals leaving the ascorbyl radical, which is relatively stable and unreactive . Previous reports have confirmed the ability of vitamin C in reducing oxidative stress [19,20]. Vitamin C also resolves the inflammatory response by influencing neutrophil chemotaxis in response to inflammatory mediators, enhancing phagocytosis of microbes by neutrophils and supporting neutrophil clearance by macrophages .
This review summarizes the current knowledge on the effects of vitamin C in combating MetS in animal and human studies. The anti-oxidative and anti-inflammatory properties of vitamin C as the primary mechanisms regulating the physiopathology of MetS are also discussed. This review may be instructive for people with MetS, healthcare professionals who care for individuals with MetS and researchers who conduct studies on MetS.
A literature search was conducted using PubMed and Scopus databases from February 15, 2020 to March 15, 2020 with keywords “(vitamin C OR ascorbic acid OR ascorbate) AND metabolic syndrome”. Our literature search identified 214 records from PubMed and 576 records from Scopus. After removing duplicated articles (n=138), the titles and abstracts were screened to remove irrelevant articles (n=610) and articles in other languages (n=9). Only articles written in English and Mandarin were included. In this review, we focus on summarising the effects of vitamin C on MetS as an entity in animals and humans. The use of vitamin C as monotherapy and/or combined therapy were included. Articles with the main purpose of investigating (a) the association between vitamin C intake or its circulating concentration in blood and risk of MetS as well as (b) the effects of vitamin C supplementation on MetS as the primary outcomes were retrieved. A total of 33 articles which met the criteria were included in this review (Figure 1).
Framework for the selection of relevant studies.
Summary on the effects of vitamin C on MetS in animals.
|Animal model||Intervention and route of administration||Treatment duration||MetS components||Mechanism of action||Reference|
|Wistar rats fed on high salt (8% NaCl) diet||Vitamin C (100 mg/kg) - oral||4 weeks||Weight gain: ↓||Glucose: ↓,|
|Systolic BP: ↓||TC: ↓,|
|Vitamin C: ↑,|
Total antioxidant status: ↑,
|Vitamin A (6 mg/kg) + vitamin C (100 mg/kg) + vitamin E (60 mg/kg) - oral||Weight gain: ↓||Glucose: ↓,|
|Systolic BP: ↓||TC: ↓,|
|Male and female mutant Wrn∆hel/∆hel mice||0.4% sodium ascorbate (w/v) - oral||9 months||Visceral fat weight: ↓||FBG: ↓,|
|-||TG: ↓||ROS: ↓,|
DNA damage: ↓
|Male albino rabbits induced by alloxan monohydrate||Vitamin C (150 mg/kg) - oral||2 weeks||-||Glucose: ↓||BP: ↓||TG: ↓,|
Time for sdLDL oxidation: ↑, PON-1: ↑
|Lipid peroxidation: ↓,|
|Male Sprague-Dawley rats||Antioxidants cocktail [containing S-adenosylmethionine (0.5 g/kg diet), vitamin C (12.5 g/kg diet) and vitamin E (1.5 g/kg diet)] - oral||43 weeks||Fat pad mass: ↓,|
Perienteric & epididymal fat mass: ↓
|Postprandial glucose: ↔,|
Postprandial insulin: ↔,
|Male Sprague-Dawley rats fed with 5% sucrose-supplemented water||Antioxidants cocktail [containing S-adenosylmethionine (0.5 g/kg diet), vitamin C (12.5 g/kg diet) and vitamin E (1.5 g/kg diet)] - oral||43 weeks||Whole body fat mass: ↓,|
Total visceral fat mass: ↓,
Perinephric fat mass: ↓,
Perienteric fat mass: ↓
|Fasting glucose: ↓,|
Fed glucose: ↓,
Fasting insulin: ↓,
Fed insulin: ↓
|Male Sprague-Dawley rats fed with high-fat diet||Fixed dose combination of natural antioxidants (vitamin C, green tea polyphenols and grape seed extract proanthocyanidin) - oral||4 weeks||Body weight: ↓,|
Average fat coefficient: ↓,
Amount of fat in epididymal and perirenal white adipose tissue: ↓,
Cell size in adipose tissue: ↓
Glucose tolerance: ↑
|Female T2DM KK-ay mice fed with high-fat diet||-||FBG: ↓,|
Glucose tolerance: ↑
Abbreviation: AI: atherogenic index; BP: blood pressure; CRP: C-reactive protein; DNA: deoxyribonucleic acid; HISS: hepatic insulin sensitizing substance; HOMA-IR: homeostatic model assessment of insulin resistance; LDL-C: low-density lipoprotein cholesterol; MAP: mean arterial pressure; MDA: malondialdehyde; PBG: postprandial blood glucose; PON-1: paraoxonase-1; RBG: random blood glucose; RIST: rapid insulin sensitivity test; ROS: reactive oxygen species; sdLDL: small dense low-density lipoprotein; TC: total cholesterol; TG: triglycerides; VLDL-C: very low-density lipoprotein cholesterol.
The effects of vitamin C on MetS: evidence from animal studies
The effects of vitamin C supplementation on MetS have been explored in rodents and rabbits (Table 1). Bilbis et al. (2012) investigated the effects of vitamin C in the management of MetS traits using hypertensive Wistar rats placed on high salt [8% sodium chloride (NaCl)] diet. Supplementation of vitamin C for 4 weeks decreased the percentage weight gain, systolic BP, glucose, insulin, insulin resistance [evidenced by decreased homeostatic model assessment of insulin resistance (HOMA-IR)], TC, TG, LDL-C, VLDL-C, atherogenic index and increased vitamin C concentration in the salt-loaded animals . However, salt-induced hypertension is not a good model of MetS as high dietary salt is not the only factor contributing to the occurrence and progression of MetS in humans. Thus, this animal model does not resemble the human disease state of MetS. In a different animal model, Lebel et al. (2010) utilised a Werner syndrome mouse model to examine the effects of sodium ascorbate (0.4% w/v) on metabolic abnormalities. Werner syndrome is an autosomal recessive genetic disorder, characterized by accelerated ageing and displaying features of skin atrophy, wrinkles, loss of hair, atherosclerosis, as well as abnormal glucose and lipid metabolism . The outcomes of the study indicated that ascorbate-supplemented drinking water decreased visceral fat weight, TG, blood glucose and normalised insulin resistance index (evidenced by decreased HOMA-IR) in liver and heart of mutant Wrn∆hel/∆hel mice (a knockout mouse model generated by deleting the RecQ helicase domain of the mouse Wrn homologue gene) . In diabetic rabbits induced by alloxan monohydrate, administration of vitamin C (150 mg/kg) dissolved in drinking water for 2 weeks reversed the elevated mean blood glucose, systolic and diastolic BP and TG level. The concentration of HDL-C in the diabetic rabbits administered with vitamin C was increased as compared to the non-treated controls .
Researchers have also attempted to elucidate the effects of vitamin C in combination with other antioxidants, such as polyphenols or vitamins in managing MetS. Two studies were conducted by the same group of researchers to study the impact of an antioxidant cocktail containing S-adenosylmethione (0.5 g/kg diet), vitamin C (12.5 g/kg diet) and vitamin E (1.5 g/kg diet) in the development of hepatic insulin sensitizing substance (HISS)-dependent insulin resistance (HDIR) and adiposity with increasing age [26,27]. In the first study, male Sprague-Dawley rats were divided into two groups: one group received standard chow diet while the other group received standard chow diet enriched with an antioxidant cocktail. At the age of 12 months, the intake of antioxidant cocktail resulted in decreases in total fat pad mass, perienteric fat mass and epididymal fat mass as compared to the rats of the same age but without antioxidants in the diet. Besides, ageing rats receiving antioxidant cocktail from the diet showed improved HDIR as shown by higher rapid insulin sensitivity test (RIST) index and HISS component than the group not receiving the antioxidant cocktail . In the subsequent year, male Wistar rats were assigned with a standard diet supplemented with an antioxidant cocktail and 5% sucrose drinking water. Comparing to the age-matched non-treated sucrose-fed animals, the administration of antioxidant cocktail via diet blunted the elevation of fasting glucose, postprandial glucose, fasting insulin, postprandial insulin, whole body fat mass, visceral fat mass, TG but increased HDL-C. Similar to the previous study, improved insulin sensitivity was noted in the sucrose-fed animals treated with an antioxidant cocktail .
Using high salt diet-induced hypertensive rats, treatment with combined vitamins (6 mg/kg of vitamin A, 100 mg/kg of vitamin C and 60 mg/kg of vitamin E) prevented MetS component (indicated by reductions in weight gain, BP, glucose level, insulin resistance and improved lipid profile) compared to the non-treated hypertensive rats . Recently, Gao et al. (2015) tested a fixed-dose combination of natural antioxidants consisting vitamin C, green tea polyphenol and grape seed extract proanthocyanidin on MetS using male Sprague-Dawley rats and female type 2 diabetes mellitus (T2DM) KK-ay mice fed on a high-fat diet. Their data revealed that the combination of antioxidant decreased body weight, average fat coefficient, average liver coefficient, total amount of fat in epididymal and perirenal white adipose tissue, size of cell in adipose tissue, TG, LDL-C, FBG, random blood glucose (RBG), 2-hour postprandial blood glucose (PBG) and increased HDL-C in high-fat diet-induced MetS rats. In KK-ay mouse model treated with a combination of antioxidants, the diabetic phenotype and lipid disorders were ameliorated (characterized by lowered FBG, RBG, PBG, TC, TG, LDL-C and raised HDL-C) .
Among the animal studies included in this review, some studies investigated the effects of vitamin C alone, while some studies evaluated the integrative effects of vitamin C and other compounds. Even though findings from these studies showed promising effects of vitamin C supplementation in combating MetS, further validations are necessary owing to the limited animal studies on the effects of vitamin C alone. It is rather challenging to conclude that vitamin C is responsible for the observed beneficial effects when the animals were treated with the combination of vitamin C with other compounds. The comparison between study outcomes is also difficult to performed due to the heterogeneity of compounds as the intervention. Another important aspect to note is the ability to compensate for vitamin C through L-gulonolactone in animals. Thus, the consumption of diet containing vitamin C may not change the plasma concentration of vitamin C. In this case, the use of animals is not an ideal model to mimic human situation. Study should be carried out to measure and compare plasma vitamin C concentration before and after supplementation of vitamin C. The positive outcomes from animal studies also prompt the need to look further into the available evidence on the association between vitamin C and MetS in humans.
The effects of vitamin C on MetS: evidence from human studies
In this section, the potential of vitamin C in reversing MetS in human as evidenced by cross-sectional and case-controlled studies will be summarized. The current documented literature showed heterogeneous findings, whereby possible or negligible relationships between vitamin C intake / concentration and MetS have been reported. The interventional trials conducted by researchers also revealed positive or no effect of vitamin C supplementation on MetS conditions (Table 2).
Summary on the effects of vitamin C on MetS in humans.
|Study design||Study population||Vitamin C intake / concentration||Findings||Reference|
|Cross-sectional study||Adults participating in KNHANES 2007 - 2012 (n=27,656; aged ≥20 years)||Intake of vitamin C||MetS subjects had lower vitamin C intake.|
Higher vitamin C intake lowered the risk of MetS.
|Cross-sectional study||Adults participating in KNHANES 2008 - 2012 (n=22,671; aged ≥20 years)||Intake of vitamin C||Individuals with high vitamin C intake alone, high physical activity alone as well as both high physical activity and vitamin C intake had lower waist circumference.|
Individuals with both high physical activity and vitamin C intake had lower TG and higher HDL-C.
High vitamin C intake alone, high physical activity alone and both high physical activity and vitamin C intake were associated with low risk of MetS.
|Cross-sectional study||Adults participating in KNHANES 2013 - 2016 (n=10,351; aged 19 - 64 years)||Intake of vitamin C||Men in the highest tertile of vitamin C intake had a lower prevalence of MetS than those in the lowest tertiles.|
Women in the highest tertile of vitamin C intake had lower TG than those in the lowest tertile.
|Cross-sectional study||MetS patients (n=221; aged 54.2 ± 5.73 years) and control subjects (n=329; aged 53.3 ± 5.83 years)||Intake of vitamin C||MetS patients had lower vitamin C intake, SOD activity, β-carotene level but higher MDA content|
Dietary vitamin C was positively related with serum antioxidant level.
|Cross-sectional study||Patients diagnosed with colorectal cancer with (n=49; 52.5 ± 13.0 years) and without MetS (n=94; aged 58.0 ± 9.3 years)||Intake of vitamin C||MetS subjects had lower consumption of vitamin C.|
Higher vitamin C intake lowered the risk of MetS.
|Cross-sectional study||Volunteers attending Xiangya Hospital Health Management Centre from October 2013 until January 2014 (n=2,069; aged 18 - 84 years)||Intake of vitamin C||Vitamin C intake was inversely associated with MetS.|
Vitamin C intake showed a negative correlation with waist circumference.
|Cross-sectional study||Adult Saudis (n=185; aged 19 - 60 years)||Intake of vitamin C||Lower intake of vitamin C caused an increased risk of having MetS.|||
|Cross-sectional study||Caucasian healthy young subjects (n=153; aged 20.8 ± 2.7 years)||Intake of vitamin C||Vitamin C intake was positively associated with total antioxidant capacity.|
Total antioxidant capacity was negatively associated with body weight, waist circumference, waist-to-hip ratio, systolic BP, serum glucose and serum free fatty acids.
|Case-control study||Healthy women (n=90; aged 41 - 65 years) and MetS women (n=184; aged 45 - 68 years)||Intake of vitamin C||Daily food rations (DFR) showed that the optimal level of 90 - 110% according to standards was only achieved in 8.88% of women with MetS for vitamin C, which was significantly less than the control group.|||
|Cross-sectional study||Adults participating in NHANES 2013 - 2016 (n=10,112; aged >19 years)||Intake of 100% fruit juice||100% fruit juice consumers had a higher intake of vitamin C compared to non-consumers.|
Intake of vitamin C increased with increasing 100% fruit juice consumption level.
100% fruit juice consumers had lower BMI, body weight, waist circumference and HbA1c compared to non-consumers.
100% fruit juice consumers had a lower risk of obesity, elevated waist circumference and MetS as compared to non-consumers.
|Case-control study||Healthy subjects (n=91; aged 41 - 65 years) and MetS patients (n=182, aged 30 - 65 years)||Intake of vitamin C and plasma vitamin C concentration||Plasma vitamin C concentration was lower in patients with MetS than in healthy subjects.|
Plasma vitamin C deficiency was more often in MetS patients than in the control group. High concentration of vitamin C was associated with low systolic BP, diastolic BP and HDL-C in MetS patients.
No correlation was found between vitamin C intake from the diet and their plasma concentration in MetS patients.
|Cross-sectional study||Adults participating in NHANES 1988 - 1994 (n=8,808; aged ≥20 years)||Intake of vitamin C and serum vitamin C concentration||Serum vitamin C concentration was lower in MetS subjects than non-MetS subjects.|
Serum vitamin C concentration was inversely associated with waist circumference, hyperglycaemia and the number of MetS criteria.
No difference in dietary intake of vitamin C among participants with and without MetS.
|Cross-sectional study||Adolescents participating in NHANES 2001 - 2006 (n=4,285; aged 12 - 19 years)||Serum vitamin C concentration||Serum vitamin C concentration was lower in MetS subjects than non-MetS subjects.|
Serum vitamin C concentration was inversely related to MetS outcomes.
|Cross-sectional study||Adults participating in NHANES 2001 - 2006 (n=1,574; aged 20 - 85 years)||Serum vitamin C concentration||Serum vitamin C concentration was lower in MetS subjects than non-MetS subjects.|
Increase in vitamin C was associated with lower odds of MetS.
|Cross-sectional study||Adults participating in NHANES 2005 - 2006 with MetS (n=2,049; aged ≥20 years)||Serum vitamin C concentration||Vitamin C decreased as BMI and number of MetS components increased.|
CRP and GGT increased when the number of MetS increased.
Having lower than the clinical reference range for vitamin C was associated with significantly higher odds of MetS.
|Cross-sectional study||Brazilian adults with and without MetS (n=85; aged 22 - 85 years)||Serum vitamin C concentration||Subjects with MetS presented a reduction in serum vitamin C concentration compared to those without MetS.|||
|Case-control study||Healthy subjects (n=100; aged 22 - 78 years) and MetS patients (n=100, aged 21 - 73 years)||Plasma vitamin C concentration||Plasma vitamin C concentration of MetS subjects was lower than that of controls.||[44,45]|
|Case-control study||Healthy subjects (n=98; aged 41 - 65 years) and MetS patients (n=191, aged 30 - 65 years)||Plasma vitamin C concentration||Plasma vitamin C concentration was lower in patients with MetS than in healthy subjects.|||
|Cross-sectional study||Participants with and without MetS from B.P. Koirala Institute of Health Sciences (n=118)||Plasma vitamin C concentration||No difference was observed in plasma vitamin C concentration between non-MetS and MetS participants.|||
|Cross-sectional study||Healthy Chinese women, PCOS women and PCOS women with MetS (n=205; aged 21 - 40 years)||Serum vitamin C concentration||No difference was detected in serum vitamin C concentration between PCOS women with and without MetS.|
Lower SOD, total antioxidant activity and higher MDA were detected in PCOS women with MetS as compared to healthy controls.
|Randomised double-blind, placebo-controlled trial||Adults participating in SUpplementation en VItamines et Mineraux AntioXydants (SU.VI.MAX) primary prevention trial (n=5,220)||Supplementation with antioxidants (120 mg vitamin C, 30 mg vitamin E, 6 mg β-carotene, 20 mg zinc and 100 μg selenium)||Antioxidants supplementation for 7.5 years did not affect the risk of MetS.|
Higher baseline serum vitamin C concentration was associated with a lower risk of MetS (OR=0.53; 95% CI 0.35 - 0.80).
|Randomised controlled trial||MetS patients (n=141; aged 30 - 50 years)||Supplementation with vitamin C (500 mg/day) alone or in combination with physical activity||Taking vitamin C with exercise lowered waist circumference and increased HDL-C compared to placebo.|
Taking either vitamin C or vitamin C with exercise lowered TG compared to placebo.
|Randomised double-blinded, placebo-controlled trial||MetS patients (n=96, aged 30 - 60 years)||Supplementation with vitamin C (500 mg/day) alone or in combination with physical activity||Vitamin C plus exercise decreased systolic BP compared to placebo.|
Vitamin C supplementation decreased BMI and LDL-C compared to the placebo group.
|Double-blinded, controlled trial||Postmenopausal women with T2DM (n=69; aged 50 - 65 years)||Supplementation with zinc (5 mg) plus vitamin C (300 mg)||Supplementation with zinc plus vitamin C decreased systolic and diastolic BP but increased FBG and HDL-C.|||
|Randomised controlled trial||MetS patients (n=72; aged 48 ± 9 years)||Adopted a balanced diet only or adopted|
a balanced diet plus orange juice (500 mL/day)
|Both interventions decreased body weight, BMI, waist circumference, fat mass, visceral fat area, glucose, TC, HDL-C, systolic BP, diastolic BP and increased antioxidant capacity.|
Only patients adopting a balanced diet plus orange juice had lower insulin, insulin resistance, CRP and hsCRP.
|Randomised controlled trial||MetS patients (n=81; aged 35 - 65 years)||Low sodium vegetable juice (8 or 16 ounces/day)||Groups consuming vegetable juice had a higher intake of vitamin C, lower leptin level and lost more weight.|||
Abbreviation: BMI: body mass index; BP: blood pressure; CRP: C-reactive protein; DFR: daily food rations; FBG: fasting blood glucose; GGT: γ-glutamyl transferase; HbA1c: glycated haemoglobin; HDL-C: high-density lipoprotein cholesterol; hsCRP: high sensitivity C-reactive protein; KNHANES: Korea National Health and Nutrition Examination Survey; MDA: malondialdehyde; MetS: metabolic syndrome; PCOS: polycystic ovary syndrome; SOD: superoxide dismutase; TC: total cholesterol; TG: triglycerides.
The relationship between vitamin C intake and MetS
Three relatively large cross-sectional studies were conducted among the general Korean population to investigate the association between vitamin C intake and risk for MetS. All these studies used data from the Korea National Health and Nutrition Examination Survey (KNHANES). Between the year 2007 until 2012, daily intake of vitamin and MetS parameters were collected among 27,656 adults with ≥ 20 years of age. The authors found that the vitamin C intake was lower in the MetS group (73.4 ± 1.2% of the recommended intake) than non-MetS group (80.1 ± 0.7% of the recommended intake). With a two-fold increase in total vitamin C intake in women, the incidence of MetS decreased [odd ratio (OR) = 0.933; 95% confident interval (CI) 0.883 to 0.987] . Kim & Choi (2016) analysed information from 22,671 adults aged 20 years or older to examine the integrative effects of physical activity and dietary vitamin C on the risk of MetS. They found a substantial decrease in waist circumference in individuals with high vitamin C intake alone (OR = -0.3; 95% CI -0.6 to -0.1), high physical activity alone (OR = -0.6; 95% CI -0.8 to -0.4) as well as both high vitamin C intake and physical activity (OR = -1.0; 95% CI -1.2 to -0.8). Apart from that, TG level was decreased whereas HDL-C level was increased in individuals with both high vitamin C intake and physical activity. Consistent findings were obtained after sub-analysis based on sex was performed. They also found lower risk of MetS in the high vitamin C intake alone (OR = 0.89; 95% CI 0.80 to 0.99), high physical activity alone (OR = 0.81; 95% CI 0.73 to 0.90) as well as both high vitamin C intake and physical activity groups (OR = 0.79; 95% CI 0.71 to 0.87) . Another study was conducted using data between 2013 until 2016 composed of 10,351 adults aged 19 - 64 years. In men, the prevalence of MetS was lower in the highest tertile of vitamin C intake than the lowest tertile (OR = 0.75; 95% CI 0.58 to 0.95). In women, TG level was lower in the highest tertile of vitamin C intake compared to the lowest tertile (OR = 0.75; 95% CI 0.61 to 0.93) .
In line with these studies, Li and co-researchers reported that MetS patients (n=221; aged 54.2 ± 5.73 years) exhibited lower vitamin C intake than control subjects (n=329; aged 53.3 ± 5.83 years) after adjusting for confounding factors, such as age and sex . A reverse correlation was found between vitamin C intake and risk of MetS in three different study populations, i.e. patients with colorectal cancer (OR = 0.89; 95% CI 0.84 to 0.94) , volunteers undergoing regular health check-up at Xiangya Hospital Health Management Centre in China (OR = 0.64; 95% CI 0.43 to 0.94)  and Saudi adults (OR = 4.1; 95% CI 1.6 to 8.3) . Other observations found in these studies were the significantly higher consumption of vitamin C in colorectal cancer patients without MetS (92.7 ± 21.3 mg) than those with MetS (63.1 ± 34.0 mg)  and vitamin C intake displayed a negative association with waist circumference . Godala and colleagues examined the Polish population consisting of 90 clinically healthy women (aged 57.48 ± 5.79 years) and 184 women with MetS (aged 57.38 ± 8.17 years) and reported that the optimal level of 90 - 110% for vitamin C intake was only achieved in 8.88% of women with MetS which was significantly less often than in the control group .
A report recently published by Agarwal et al. (2019) provided an updated evaluation of the association between 100% fruit juice consumption with nutrient intake and risk factors for MetS . The study population in this study was 10,112 adults aged 19 years old and above participating in NHANES 2013 - 2016. The consumers of 100% fruit juice (defined as those consuming any amount of 100% fruit juice during the first 24 hours dietary recall) had a significantly higher intake of vitamin C compared to non-consumers, with the intake of vitamin C increased as the 100% fruit juice consumption level increased. As compared to the non-consumers, the 100% fruit juice adult consumers had lower BMI, body weight, waist circumference, plasma glucose and glycated haemoglobin (HbA1c). The risk for being overweight or obese (OR = 0.78; 95% CI 0.65 to 0.95), raised waist circumference (OR = 0.69; 95% CI 0.56 to 0.85) and having MetS (OR = 0.73; 95% CI 0.58 to 0.93) was also decreased in adult consumers of 100% fruit juice .
Godala et al. (2016b) did not find a correlation between vitamin C intake from the diet and the plasma concentration of vitamin C in MetS patients recruited from the Department of Internal Medicine and Nephrodiabetology, Medical University of Lodz, Poland. The authors postulated that the increased oxidative stress in the MetS group was counteracted by greater consumption of vitamin C in neutralising ROS, thus decreased concentration of plasma vitamin C could be expected . A study by Ford et al. (2003) also reported no difference in dietary intake of vitamin C among participants involved in NHANES 1988 - 1994 with and without MetS (n=8,808; aged ≥20 years). This observation might have resulted from similar vitamin or mineral use during the previous 24 hours and past month . These studies found two major outcomes on vitamin C intake in MetS subjects: (a) there was no correlation between vitamin C intake and plasma concentration of vitamin C and (b) there was no difference between dietary intake between the subjects with and without MetS. As compared to the previously aforementioned studies, the association between vitamin C intake and the prevalence of MetS was not evaluated in these two studies. Owing to the vitamin C intake data in these studies served as an estimation and it can be prone to a number of confounders, the vitamin C status in plasma or serum would provide a more accurate representation.
The relationship between circulating vitamin C concentration and MetS
Four cross-sectional studies involving adolescents and adults participating in National Health and Nutrition Examination Survey (NHANES) demonstrated that serum vitamin C concentration was inversely correlated with MetS outcomes [39-42]. Using data from NHANES between 1988 until 1994, the serum vitamin C concentration was compared among 8,808 adults (aged 20 years and above) with and without MetS. Findings from this study indicated that the age-adjusted concentration of vitamin C was lower in participants with MetS (36.41 ± 1.11 mmol/L) than those without MetS (42.94 ± 0.83 mmol/L). The concentration of vitamin C was inversely correlated with waist circumference (β = -4.090 ± 0.860) and hyperglycaemia (β = -3.066 ± 1.017). Besides, individuals with the highest number of MetS criteria had the lowest serum vitamin C concentration . From the year 2001 to 2006, Beydoun and colleagues performed two cross-sectional studies recruiting 4,285 adolescents (aged 12 - 19 years) and 1,574 adults (aged 20 - 85 years), respectively. In adolescents, lower concentration of vitamin C in serum was noted in participants with MetS than those without MetS. Inverse relationships were constantly found between vitamin C and MetS using different models, i.e. after controlling for socio-demographic and dietary factors (OR = 0.26; 95% CI 0.11 to 0.62) as well as after inclusion of serum cholesterol and TG (OR = 0.16; 95% CI 0.05 to 0.52) . A similar trend was detected in adults whereby MetS subjects displayed lower vitamin C concentration compared to non-MetS subjects. Vitamin C was inversely related to MetS count and binary outcomes. Every increase of ~28.5 μmol/L in vitamin C concentration was associated with 24% lower prevalence odds of MetS (OR = 0.76; 95% CI 0.58 to 0.98) . More recently, a cross-sectional study was published consisting of data from NHANES between 2005 until 2006. A total of 2,049 MetS subjects were identified using the harmonized criteria from the Joint Interim Statement in this study. The authors unveiled that vitamin C concentration decreased with increasing BMI and number of MetS components. In addition, having lower than the clinical reference range for vitamin C was significantly associated with a greater likelihood of MetS (OR = 1.39; 95% CI 1.01 to 1.90) .
Another cross-sectional study by Chielle et al. (2018) recruited 85 Brazilian adults (36 MetS subjects and 48 healthy volunteers) aged 22 - 85 years from January to May 2017. The MetS group had a significant decrease in vitamin C concentration when compared to the group without MetS . Comparative results were obtained from case-control studies assessing the relationship between plasma vitamin C status and MetS components. Odum and co-researchers recruited 200 Nigerians consisting of 100 MetS subjects as well as 100 age- and sex-matched controls. The mean plasma vitamin C concentration of the study population was measured and a significantly lower concentration of vitamin C was observed in MetS individuals as compared to the healthy subjects [44,45]. Two case-control studies by Godala and co-researchers estimated the plasma vitamin C concentration in MetS patients (aged 30 - 65 years) and healthy subjects (aged 41 - 65 years). MetS subjects were found to have a lower plasma vitamin C concentration relative to healthy controls. Deficiency of circulating vitamin C concentration was significantly more common in MetS subjects than healthy individuals. The concentration of vitamin C in MetS patients was found to inversely correlate with systolic BP (Pearson's coefficient: -0.31, p<0.0001), diastolic BP (Pearson's coefficient: -0.1689, p=0.042) and HDL-C (Pearson's coefficient: -0.19, p=0.018) [38,46].
On the contrary, two cross-sectional studies reported paradoxical results. A total of 118 healthy participants working at B.P. Koirala Institute of Health Sciences, Dharan, Nepal were included in a cross-sectional study. They reported that 39% subjects (n=46) were diagnosed with MetS and no significant difference was observed in the plasma vitamin C concentration among individuals with and without MetS. Furthermore, other oxidative stress parameter and antioxidant levels including malondialdehyde (MDA), reduced glutathione (GSH), glutathione peroxidase (GPx), superoxide dismutase (SOD) and vitamin E were not significantly different among the subjects with and without MetS. The authors suggested that oxidative stress did not contribute in the pathogenesis of MetS in this population . Wang et al. (2019) conducted a cross-sectional study among 205 Chinese women consisting of 65 healthy women, 150 women with polycystic ovary syndrome (PCOS) as well as 55 women with PCOS and MetS (aged 21 - 40 years). Findings from this study demonstrated no difference in serum vitamin C concentration among the three groups of subjects. The discrepancy observed in the findings of this study compared to other studies might be due to the presence of other antioxidants in counteracting the oxidative stress during MetS. The levels of SOD and total antioxidant activity were lower in PCOS women with MetS as compared to healthy control .
The effects of vitamin C supplementation on MetS
The earliest clinical trial investigating the effects of vitamin C on MetS was conducted by Czernichow et al. (2009). They designed a randomised double-blind placebo-controlled, primary prevention trial, known as the French SUpplementation en VItamines et Mineraux AntioXydants (SU.VI.MAX) study. A total of 5,220 men and women were included and randomly assigned to receive either a supplement containing a combination of antioxidants (120 mg vitamin C, 30 mg vitamin E, 6 mg β-carotene, 20 mg zinc and 100 μg selenium) or a placebo. The participants were free of MetS during the onset of the study and were followed for 7.5 years. Results from this study pinpointed that antioxidant supplementation for 7.5 years did not affect the incident risk of MetS, as shown by an approximately equal number of MetS events in the placebo and intervention groups. However, higher baseline serum vitamin C concentration was associated with lower odds for MetS incident risk (OR = 0.53; 95% CI 0.35 to 0.80) .
The effects of vitamin C supplementation alone or in combination with endurance physical activity were investigated by Farag and co-authors in two randomised controlled trials. In the first study, participants of both sexes with MetS (n=141; aged 30 - 50 years old) were randomly divided into six groups receiving placebo, 2000 IU/day vitamin D or 500 mg/day vitamin C with or without 30 minutes/day physical activities for three months. Their data concluded that subjects taking vitamin C alone had a lowered TG level compared to placebo. The level of HDL-C was increased, but TG and waist circumference were decreased in MetS patients subjected to vitamin C supplementation with exercise in relative to the placebo . Another randomised double-blind, placebo-controlled trial by the same group of researchers involved 96 MetS patients aged between 30 to 60 years old. It was worthy to note that vitamin C supplementation alone decreased BMI and LDL-C compared to the placebo group. The MetS patients had lower systolic BP after taking vitamin C supplements and undergoing physical activity for three months than the placebo controls .
Recently, Mahmoodi et al. (2019) designed a double-blind controlled trial to elucidate the influence of zinc (5 mg) and vitamin C (300 mg) in combination on MetS parameters in postmenopausal women with T2DM (n=69; aged 50 - 65 years). The supplementation of zinc plus vitamin C for 12 weeks resulted in higher FBG and HDL-C as well as lower systolic and diastolic BP . In the same year, Ponce et al. (2019) tested whether adopting a balanced diet alone or adopting a balanced diet plus daily intake of orange juice attenuated risk factors in individuals with MetS (n=72; aged 48 ± 9 years). Subjects who were consuming a balanced diet and orange juice daily (328 ± 35 mg) obtained a significantly higher concentration of vitamin C in their nutritional composition of the meal as compared to those who only took a balanced diet (145 ± 42 mg). Both interventions improved MetS features, indicated by decreased body weight, BMI, waist circumference, fat mass, visceral fat area, blood glucose, TC, HDL-C and BP. Only the combination of a balanced diet together with the intake of orange juice lowered insulin and insulin resistance . Shenoy et al. (2010) also evaluated the impact of a ready serve vegetable juice on MetS-associated parameters among men and women (n=81; aged 35 - 65 years) who met the criteria for MetS set by National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) Panel III. The participants were randomised into three groups receiving no vegetable juice, 8 or 16 ounces of low sodium vegetable juice per day for 12 weeks. The authors pointed out that the groups provided with vegetable juice had a higher intake of vitamin C and lost more weight as compared to the group who did not drink the juice .
The current evidence shows that high vitamin C intake, concentration and supplementation are beneficial in reversing MetS except for a few studies. Several key points can be summarized based on the findings from the aforementioned studies. Firstly, MetS subjects had lower vitamin C intake and circulating concentration. Secondly, low vitamin C intake and circulating concentration are closely linked with a high risk of MetS. Thirdly, there was no correlation between vitamin C consumption and plasma concentration. Hence, it has been postulated that vitamin C was consumed when neutralizing inflammation and free radicals. Greater consumption of vitamin C was needed due to higher inflammatory response and oxidative stress in people with MetS. Furthermore, all randomised controlled trial included in this review investigated the effects of vitamin C supplementation in combination with other antioxidants or exercise on MetS. Similar to animal studies, it is hard to justify whether the beneficial effects in improving MetS abnormalities were contributed by vitamin C or other compounds that present in the combined therapy. However, it can be suggested that the supplementation of vitamin C in combination with other antioxidants or exercise may provide synergistic effects in the management of MetS and its associated conditions.
The potential mechanism of action for vitamin C in the management of MetS
The anti-oxidative property of vitamin C
Oxidative stress, an imbalance between the production and inactivation of ROS, is the hallmark of MetS . Several biochemical mechanisms of ROS formation during MetS have been postulated. Unhealthy eating habits (such as consuming a diet rich in fat and carbohydrate), as well as low physical activity, are the contributing factors of MetS [6,56]. In the state of overnutrition, the large flux of macronutrients exacerbates oxidation process resulting in higher ROS generation and postprandial oxidative stress response . The increase in adipose tissues stimulates excessive production of pro-inflammatory mediators, which in turn stimulate macrophages and monocytes to generate ROS . Hypertrophied adipocytes also secrete angiotensin II to enhance ROS production from nicotinamide adenine dinucleotide phosphate (NADPH) oxidase . Under physiological condition, the synthesis of ROS is often counteracted by the natural antioxidant system in the body consisting of a series of enzymatic and non-enzymatic antioxidants. The examples of enzymatic antioxidants are SOD, GPx and catalase (CAT) whereas the non-enzymatic antioxidants include GSH, vitamin C, vitamin E, beta (β)-carotene and other phytochemicals. The perturbation of ROS and antioxidant balance is often due to an increase in ROS production or/and a depression of the antioxidant system. High level of ROS reacts with cellular macromolecules and causes lipid peroxidation . Thus, the products of lipid peroxidations are often the biomarkers for oxidative stress.
The protective effects of vitamin C against oxidative stress have been presented in MetS animal models (Table 1). Using Wistar rats fed with a high-salt diet, the orally supplemented 100 mg/kg vitamin C for 4 weeks increased vitamin C concentration, total antioxidant status and decreased MDA content in animals as compared to non-treated negative controls . Another study showed that the mutant Wrn∆hel/∆hel mice treated with drinking water enriched with 0.4% sodium ascorbate decreased oxidative stress in liver and heart tissues [the levels of ROS and deoxyribonucleic acid (DNA) damage decreased] along with the reversal of metabolic phenotypes . In the rabbit model, results from comet assay showed that the DNA damage in lymphocytes of the diabetic group without supplementation of vitamin C was higher (indicated by longer tail length) and a reduction was seen in the vitamin C-treated group. Simultaneously, serum MDA was also higher in diabetic group and decreased after vitamin C supplementation. The serum paraoxonase-1 (PON-1) activity and time required for small dense low-density lipoprotein (sdLDL) oxidation were low in the diabetic group. These parameters increased after vitamin C supplementation . The investigation using animal model of MetS induced by high-fat diet displayed MetS features and high degree of oxidation (MDA level) in the body. Feeding the animals with a fixed-dose combination of vitamin C, green tea polyphenols and grape seed extract proanthocyanidin successfully ameliorated the oxidative stress .
In a cross-sectional study, Li et al. (2013) found that MDA content was significantly higher, whereas the SOD activity and β-carotene level were significantly lower in the MetS patients. Serum SOD and GPx activity were decreased as the number of MetS components increased. Higher SOD activity (OR = 0.506; 95% CI 0.303 to 0.844) and β-carotene level (OR = 0.097; 95% CI 0.026 to 0.374) were associated with lower odds of MetS after adjusted for age and gender. The analysis of correlation found a positive association between vitamin C intake and serum antioxidant level . MetS parameters and total antioxidant capacity adjusted by daily energy intake were measured by Puchau et al. (2010) in a study involving 153 Caucasian healthy young subjects (aged 20.8 ± 2.7 years). The results showed that dietary total antioxidant capacity was positively associated with vitamin C (r = 0.29, p < 0.001) but negatively associated with body weight (r = -0.18, p = 0.025), waist circumference (r = -0.18, p = 0.029), waist-to-hip ratio (r = -0.16, p = 0.048), systolic BP (r = -0.19, p = 0.018) and serum glucose (r = -0.26, p = 0.001). Serum free fatty acid was also appeared to be negatively associated with dietary total antioxidant capacity in multiple linear regression analysis (OR = -0.09; 95% CI -0.16 to -0.03) . In line with these studies, it was observed that the level of γ-glutamyl transferase (GGT) was increased as the number of MetS indicators increased among the population in the United States indicating damage to the liver and bile ducts . Several oxidative markers were evaluated in Brazilian adult with and without MetS. The MetS subjects presented the increases in GGT, glutamic-pyruvic transaminase (GPT), glutamic-oxaloacetic transaminase (GOT), total ferric antioxidant power (FRAP), sulfhydryl groups (SH) and thiobarbituric acid reactive substances (TBARS) . By contrasting the oxidative stress indicators and anti-oxidative capacity in healthy controls, the MDA level was higher whereas the levels of SOD and total antioxidant activity were lower in PCOS subjects with MetS . In a randomised controlled trial, MetS patients assigned with a balanced diet and 500 mL/day orange juice over 12 weeks had higher vitamin C intake with a concomitant increase in antioxidant capacity .
The anti-inflammatory property of vitamin C
Chronic low-grade inflammation is a common feature accompanying MetS and its associated complications . It is characterized by the activation of inflammatory signalling networks resulting in dysregulation of adipokines, overwhelming production of cytokines and chemokines in the systemic circulation . Generally, the hyperplasia and hypertrophy of adipose tissue (the main source of various inflammatory mediators) contribute to the development of MetS-associated inflammation. High levels of inflammatory mediators further promote the recruitment and accumulation of macrophages in adipose tissue, exacerbating the state of inflammation during MetS . Humans with MetS experience chronic systemic inflammation. In addition, adiposity is also asscociated with increased level of inflammatory markers, indicating that adipose tissue is a significant contributor of inflammatory conditions in MetS . Obesity, in the absence of MetS, is also known to be associated with an inflammatory state. The presence of other MetS features (hyperglycaemia, hypertension and dyslipidaemia) may exacerbate the inflammatory condition because each component of MetS brings about the increase in local and systemic production of pro-inflammatory cytokines [65-67]. A human study by Genel et al. (2014) indicated that inflammation was more prominent in MetS subjects with higher number of elements that define MetS . In addition, oxidative stress is also a critical activator for inflammation. The augmentation in ROS production, NADPH oxidase expression and decrease in antioxidant levels exert significant disturbance in the production of adiponectin, interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1) . Another postulation is that the link between MetS and inflammation is mediated through the activation of Toll-like receptor (TLR) signalling cascade . The increase in exogenous pathogen-associated molecular patterns and endogenous damage-associated molecular patterns during MetS is recognised by TLRs. Subsequently, the binding of these molecular patterns to TLRs activates downstream signalling components to induce the release of inflammatory cytokines [71,72].
Vitamin C showed beneficial effects in alleviating inflammatory response in vivo (Table 1). The level of C-reactive protein (CRP) was higher in alloxan monohydrate-induced diabetic rabbits than those supplemented with 150 mg/kg ascorbic acid . Comparably, human studies indicated that vitamin C decreased inflammation in MetS conditions (Table 2). In the United States population, vitamin C concentration correlate negatively with the number of MetS indicators and CRP level . It was also estimated that the level of IL-6 was increased in Brazilian adults with MetS . For MetS patients provided with a balanced diet and 500 mL/day orange juice, higher vitamin C intake but lower CRP and high sensitivity C-reactive protein (hsCRP) levels were observed after three months of intervention .
Other potential biological functions of vitamin C
Vitamin C has many biological functions aside from its anti-oxidative and anti-inflammatory properties. Vitamin C acts as a co-factor for biosynthesis of carnitine, a molecule that is required in the mitochondrial oxidation of fatty acid [73,74]. An increase in the concentration of vitamin C elevates the body's capability to oxidize fat, thus suggesting an inverse relationship between vitamin C status and adiposity . Vitamin C also influences the activation of glycolysis via hypoxic signalling. Hypoxia is an event that commonly occurs in MetS-associated conditions due to the uncoupling of oxidation and phosphorylation in mitochondrial respiration and increased oxygen consumption . Hypoxic condition favours higher rate of glycolysis through stabilisation of hypoxia-inducible factor-1 (HIF-1) . Interestingly, the rate of re-esterification of free fatty acid is directly proportional to the production of glycerol-3-phosphate via glycolysis, resulting in formation and accumulation of TG. High concentration of vitamin C has been reported to degrade HIF-1 and subsequently inhibit glycolysis .
In short, oxidative stress and inflammation are two interrelated conditions that characterize the pathophysiology of MetS and its related manifestations. The rise in inflammatory mediators could be responsible for the increase in ROS and vice versa. The anti-oxidative and anti-inflammatory properties of vitamin C are likely the mechanisms of action that substantially reverse MetS. Moreover, fatty acid metabolism and glycolysis can also be affected by the alteration of vitamin C availability and intake.
Research gap and future perspectives
The current global Recommended Daily Allowance (RDA) for vitamin C varies dramatically across countries, ranges from 40 mg/day in United Kingdom and India to 110 mg/day in European countries to achieve the adequate needs to maintain the balance between oxidative stress and antioxidant protection . These values need to be increased for smokers as cigarette smoking increases oxidative stress and metabolic turnover of vitamin C as well as pregnant and lactating women due to the needs of the developing foetus and growing infant . Obesity also affects the requirement for vitamin C due to a body weight-dependent dilution effect. Epidermiological studies have demonstrated that increased body weight, fat-free mass or BMI had a negative impact on plasma vitamin C concentration [80-82]. Higher body weight might decrease the response towards vitamin C supplementation thus suggesting higher requirement . The upper tolerable level of consumption of 2 g/day is set by some countries to avoid osmotic diarrhoea and gastrointestinal disturbance due to excessive ingestion of vitamin C . In the context of vitamin C supplementation, it seems reasonable as the doses in the human clinical trials discussed above were ranged between 120 - 500 mg/day. For animals, researchers treated the rats and rabbits with 100 and 150 mg/kg whereby the human equivalent doses based on body surface area were 1.32 g and 3.41 g of vitamin C daily for a 70 kg individual. The dose assigned to the rabbits exceeded the upper tolerable level of consumption for vitamin C, which may require careful consideration for potential side effects. It should also be noted that rodents, unlike humans, can synthesize vitamin C in vivo through L-gulonolactone oxidase , hence their vitamin C requirements could not be translated to human's directly. This biological difference should be considered carefully when extrapolating the results from animal studies. Besides, most antioxidants do not act alone to exert their protective actions. The effects of vitamin C in protecting MetS should be intepretated together with other dietary antioxidants in the body. In term of absorption, humans absorb vitamin C via the sodium-dependent vitamin C transporter (SVCT1) in the intestine. The capacity of this transporter limits the concentration of vitamin C that can be achieved with oral supplement. Pharmacokinetic study has indicated that oral administration of vitamin C produced a tightly controlled peak plasma concentration .
We pointed out several research opportunities in this review. First, the direct effect of vitamin C alone on MetS needs to be confirmed in animals and human populations, which is currently not widely investigated. Second, the combination of vitamin C with other antioxidants as intervention may be advantageous in managing MetS. These compounds may act together against the development of inflammation, oxidative stress and MetS. Third, measurement of the endogenous antioxidants is of interest in the preclinical experimental setting of MetS. The effects of vitamin C on oxidative markers (such as the levels of MDA, ROS and DNA damage) were measured, but the levels of enzymatic and non-enzymatic antioxidants (such as SOD, GPx, CAT and GSH) were not assessed. Vitamin C may protect the endogenous antioxidant defence system from being overwhelmed by oxidative stress, but this speculation needs to be verified. Fourth, a series of inflammation-related biomarkers including leptin, adiponectin, tumour necrosis factor-alpha (TNF-α), interleukin-10 (IL-10) and MCP-1 should be evaluated before and after vitamin C supplementation. These biomarkers can be developed as a panel for early detection of MetS. Fifth, the characterization of the molecular mechanisms underlying the anti-oxidative and anti-inflammatory properties of vitamin C in reversing MetS conditions is warranted. It may be more efficient to unravel and target the signalling pathways orchestrating the generation of ROS and inflammatory cytokines rather than neutralizing them. Even though quenching the oxidative stress and inflammation might be the principal mechanisms of action of vitamin C, other mechanisms that affect the pathophysiology of MetS may be operating as well.
In conclusion, the promising effects of vitamin C as a dietary supplement to manage MetS and its associated conditions are evident. Individuals with MetS are encouraged to consume adequate vitamin C either from healthy food sources rich in vitamin C or through the use of vitamin C supplements if they fail to achieve the recommended dietary allowance through their daily food intake. Apart from that, vitamin C may complement physical activities, phytochemicals or pharmacological drugs to maximise the therapeutic effects and potentially minimise the side effects of conventional medications.
AI: atherogenic index; apoA1: apolipoprotein A-1; BMI: body mass index; BP: blood pressure; CAT: catalase; CI: confident interval; CRP: C-reactive protein; DFR: daily food rations; DNA: deoxyribonucleic acid; FBG: fasting blood glucose; FRAP: total ferric antioxidant power; GGT: γ-glutamyl transferase; GOT: glutamic-oxaloacetic transaminase; GPT: glutamic-pyruvic transaminase; GPx: glutathione peroxidase; GSH: reduced glutathione; HbA1c: glycated haemoglobin; HDIR: hepatic insulin sensitizing substance (HISS)-dependent insulin resistance; HDL-C: high-density lipoprotein cholesterol; HISS: hepatic insulin sensitizing substance; HOMA-IR: homeostatic model assessment of insulin resistance; hsCRP: high sensitivity C-reactive protein; IL-6: interleukin-6; IL-10: interleukin-10; KNHANES: Korea National Health and Nutrition Examination Survey; LDL-C: low-density lipoprotein cholesterol; MAP: mean arterial pressure; MCP-1: monocyte chemoattractant protein-1; MDA: malondialdehyde; MetS: metabolic syndrome; MUFA: monounsaturated fatty acid; NaCl: sodium chloride; NADPH: nicotinamide adenine dinucleotide phosphate; NF-κB: nuclear factor-kappa B; NHANES: National Health and Nutrition Examination Survey; OR: odd ratio; PBG: postprandial blood glucose; PCOS: polycystic ovary syndrome; PON-1: paraoxonase-1; PUFA: polyunsaturated fatty acid; RBG: random blood glucose; RDA: Recommended Daily Allowance; RIST: rapid insulin sensitivity test; ROS: reactive oxygen species; sdLDL: small dense low-density lipoprotein; SFA: saturated fatty acid; SH: sulfhydryl groups; SOD: superoxide dismutase; T2DM: type 2 diabetes mellitus; TBARS: thiobarbituric acid reactive substances; TC: total cholesterol; TFA: trans-unsaturated fatty acid; TG: triglycerides; TLR: Toll-like receptor; TNF-α: tumour necrosis factor-alpha; VLDL-C: very low-density lipoprotein cholesterol.
S.K.W. performed literature search and drafted the manuscript; K.-Y.C. and S.I.-N. provided critical review for the manuscript; S.I.-N gave final approval for the publication of this manuscript.
This work was supported by Universiti Kebangsaan Malaysia and Ministry of Education, Malaysia for supporting this work via MI-2019-006 and FRGS/1/2018/SKK10/UKM/03/1 grants.
The authors have declared that no competing interest exists.
1. Alberti KGMM, Eckel RH, Grundy SM. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-1645
2. Suliga E, Kozieł D, Cieśla E. et al. Association between dietary patterns and metabolic syndrome in individuals with normal weight: a cross-sectional study. Nutr J. 2015;14:55-55
3. Wong SK, Chin KY, Suhaimi FH. et al. The Effects of a Modified High-carbohydrate High-fat Diet on Metabolic Syndrome Parameters in Male Rats. Exp Clin Endocrinol Diabetes. 2018;126:205-212
4. Wong SK, Chin KY, Suhaimi FH. et al. Osteoporosis is associated with metabolic syndrome induced by high-carbohydrate high-fat diet in a rat model. Biomed Pharmacother. 2018;98:191-200
5. Wong SK, Chin KY, Suhaimi FH. et al. Effects of metabolic syndrome on bone mineral density, histomorphometry and remodelling markers in male rats. PLoS One. 2018;13:e0192416
6. Bankoski A, Harris TB, McClain JJ. et al. Sedentary activity associated with metabolic syndrome independent of physical activity. Diabetes Care. 2011;34:497-503
7. Wong SK, Chin KY, Suhaimi FH. et al. Vitamin E As a Potential Interventional Treatment for Metabolic Syndrome: Evidence from Animal and Human Studies. Front Pharmacol. 2017;8:444
8. Wong SK, Chin KY, Suhaimi FH. et al. Exploring the potential of tocotrienol from Bixa orellana as a single agent targeting metabolic syndrome and bone loss. Bone. 2018;116:8-21
9. Wong SK, Chin K-Y, Suhaimi FH. et al. The effects of palm tocotrienol on metabolic syndrome and bone loss in male rats induced by high-carbohydrate high-fat diet. J Funct Foods. 2018;44:246-254
10. Wong SK, Chin KY, Suhaimi FH. et al. The Effects of Vitamin E from Elaeis guineensis (Oil Palm) in a Rat Model of Bone Loss Due to Metabolic Syndrome. Int J Environ Res Public Health. 2018 15
11. Ristic-Medic D, Vucic V. Dietary fats and metabolic syndrome. J Nutr Health Food Sci. 2013;1:8
12. Tan BL, Norhaizan ME, Liew W-P-P. Nutrients and Oxidative Stress: Friend or Foe?. Oxid Med Cell Longev. 2018;2018:9719584-9719584
13. Bhattacharyya A, Chattopadhyay R, Mitra S. et al. Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev. 2014;94:329-354
14. Fernández-Sánchez A, Madrigal-Santillán E, Bautista M. et al. Inflammation, oxidative stress, and obesity. Int J Mol Sci. 2011;12:3117-3132
15. Johnston CS, Beezhold BL, Mostow B. et al. Plasma vitamin C is inversely related to body mass index and waist circumference but not to plasma adiponectin in nonsmoking adults. J Nutr. 2007;137:1757-1762
16. Dakhale GN, Chaudhari HV, Shrivastava M. Supplementation of vitamin C reduces blood glucose and improves glycosylated hemoglobin in type 2 diabetes mellitus: a randomized, double-blind study. Adv Pharmacol Sci. 2011;2011:195271-195271
17. Juraschek SP, Guallar E, Appel LJ. et al. Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2012;95:1079-1088
18. McRae MP. Vitamin C supplementation lowers serum low-density lipoprotein cholesterol and triglycerides: a meta-analysis of 13 randomized controlled trials. J Chiropr Med. 2008;7:48-58
19. Padayatty SJ, Katz A, Wang Y. et al. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr. 2003;22:18-35
20. Pehlivan FE. Vitamin C: An antioxidant agent. Vitamin C. 2017 p:23-35
21. Carr AC, Maggini S. Vitamin C and Immune Function. Nutrients. 2017;9:1211
22. Bilbis LS, Muhammad SA, Saidu Y. et al. Effect of vitamins A, C, and E supplementation in the treatment of metabolic syndrome in albino rats. Biochem Res Int. 2012;2012:678582-678582
23. Shamanna RA, Croteau DL, Lee J-H. et al. Recent Advances in Understanding Werner Syndrome. F1000Res. 2017;6:1779-1779
24. Lebel M, Massip L, Garand C. et al. Ascorbate improves metabolic abnormalities in Wrn mutant mice but not the free radical scavenger catechin, in Annals of the New York Academy of Sciences. 2010; p: 40-44.
25. Jain N, Naseem I, Ahmad J. Evaluation of DNA damage and metabolic syndrome parameters in diabetic rabbits supplemented with antioxidants. Fundam Clin Pharmacol. 2009;23:197-205
26. Lautt WW, Ming Z, Macedo MP. et al. HISS-dependent insulin resistance (HDIR) in aged rats is associated with adiposity, progresses to syndrome X, and is attenuated by a unique antioxidant cocktail. Exp Gerontol. 2008;43:790-800
27. Ming Z, Legare DJ, Lautt WW. Obesity, syndrome X, and diabetes: the role of HISS-dependent insulin resistance altered by sucrose, an antioxidant cocktail, and age. Can J Physiol Pharmacol. 2009;87:873-882
28. Gao M, Zhao Z, Lv P. et al. Quantitative combination of natural anti-oxidants prevents metabolic syndrome by reducing oxidative stress. Redox Biol. 2015;6:206-217
29. Park S, Ham J-O, Lee B-K. Effects of total vitamin A, vitamin C, and fruit intake on risk for metabolic syndrome in Korean women and men. Nutrition. 2015;31:111-118
30. Kim J, Choi Y-H. Physical activity, dietary vitamin C, and metabolic syndrome in the Korean adults: the Korea National Health and Nutrition Examination Survey 2008 to 2012. Public Health. 2016;135:30-37
31. Ahn S, Jun S, Kang M. et al. Association between intake of antioxidant vitamins and metabolic syndrome risk among Korean adults. J Nutr Health. 2017;50:313-324
32. Li Y, Guo H, Wu M. et al. Serum and dietary antioxidant status is associated with lower prevalence of the metabolic syndrome in a study in Shanghai, China. Asia Pac J Clin Nutr. 2013;22:60-68
33. Lim H-S, Shin E-J, Yeom J-W. et al. Association between Nutrient Intake and Metabolic Syndrome in Patients with Colorectal Cancer. Clin Nutr Res. 2017;6:38-46
34. Wei J, Zeng C, Gong QY. et al. Associations between dietary antioxidant intake and metabolic syndrome. PLoS ONE. 2015 10
35. Al-Daghri NM, Khan N, Alkharfy KM. et al. Selected dietary nutrients and the prevalence of metabolic syndrome in adult males and females in Saudi Arabia: A pilot study. Nutrients. 2013;5:4587-4604
36. Godala M, Materek-Kuśmierkiewicz I, Moczulski D. et al. Should antioxidant vitamin supplementation be applied in patients with metabolic syndrome? A case-control study. Prz Menopauzalny. 2016;15:32-38
37. Agarwal S, Fulgoni VL, Welland D. Intake of 100% fruit juice is associated with improved diet quality of adults: NHANES 2013-2016 analysis. Nutrients. 2019 11
38. Godala MM, Materek-Kuśmierkiewicz I, Moczulski D. et al. Lower Plasma Levels of Antioxidant Vitamins in Patients with Metabolic Syndrome: A Case Control Study. Adv Clin Exp Med. 2016;25:689-700
39. Ford ES, Mokdad AH, Giles WH. et al. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes. 2003;52:2346-2352
40. Beydoun MA, Atilio Canas J, Beydoun HA. et al. Serum antioxidant concentrations and metabolic syndrome are associated among U.S. adolescents in recent national surveys. J Nutr. 2012;142:1693-1704
41. Beydoun MA, Shroff MR, Chen X. et al. Serum antioxidant status is associated with metabolic syndrome among U.S. adults in recent national surveys. J Nutr. 2011;141:903-913
42. Kanagasabai T, Alkhalaqi K, Churilla JR. et al. The Association Between Metabolic Syndrome and Serum Concentrations of Micronutrients, Inflammation, and Oxidative Stress Outside of the Clinical Reference Ranges: A Cross-Sectional Study. Metab Syndr Relat Disord. 2019;17:29-36
43. Chielle EO, Gens F, Rossi EM. Oxidative, inflammatory and cardiometabolic biomarkers of clinical relevance in patients with metabolic syndrome. J Bras Patol Med Lab. 2018;54:213-219
44. Odum EP, Orluwene CG, Ejilemele AA. et al. Antioxidant status of subjects with Metabolic Syndrome in Port Harcourt, Nigeria. Niger Postgrad Med J. 2012;19:199-203
45. Odum EP, Wakwe VC. Plasma concentrations of water-soluble vitamins in metabolic syndrome subjects. Niger J Clin Pract. 2012;15:442-447
46. Godala M, Materek-Kuśmierkiewicz I, Moczulski D. et al. The risk of plasma vitamin A, C, E and D deficiency in patients with metabolic syndrome: A case-control study. Adv Clin Exp Med. 2017;26:581-586
47. Shrestha S, Chandra L, Aryal M. et al. Evaluation of lipid peroxidation and antioxidants' status in metabolic syndrome. Kathmandu Univ Med J. 2010;8:382-386
48. Wang H, Ruan X, Li Y. et al. Oxidative stress indicators in Chinese women with PCOS and correlation with features of metabolic syndrome and dependency on lipid patterns. Arch Gynecol Obstet. 2019;300:1413-1421
49. Czernichow S, Vergnaud AC, Galan P. et al. Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults. Am J Clin Nutr. 2009;90:329-335
50. Farag HAM, Hosseinzadeh-Attar MJ, Muhammad BA. et al. Comparative effects of vitamin D and vitamin C supplementations with and without endurance physical activity on metabolic syndrome patients: A randomized controlled trial IRCT20161110030823N2 IRCT 11 Medical and Health Sciences 1117 Public Health and Health Services. Diabetol Metab Syndr. 2018 10
51. Farag HAM, Hosseinzadeh-Attar MJ, Muhammad BA. et al. Effects of vitamin C supplementation with and without endurance physical activity on components of metabolic syndrome: A randomized, double-blind, placebo-controlled clinical trial. Clin Nutr Exp. 2019;26:23-33
52. Mahmoodi MR, Mehrabi Y, Kimiagar M. et al. Supplementation with omega-3 plus vitamin E and zinc plus vitamin C on metabolic syndrome components in postmenopausal women with type 2 diabetes. J Kerman Univ Medical Sci. 2019;26:43-54
53. Ponce O, Benassi R, Cesar T. Orange juice associated with a balanced diet mitigated risk factors of metabolic syndrome: A randomized controlled trial. J Nutr Intermed Metab. 2019 17
54. Shenoy SF, Poston WS, Reeves RS. et al. Weight loss in individuals with metabolic syndrome given DASH diet counseling when provided a low sodium vegetable juice: a randomized controlled trial. Nutr J. 2010;9:8-8
55. Hutcheson R, Rocic P. The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: the great exploration. Exp Diabetes Res. 2012;2012:271028-271028
56. Wong SK, Chin K-Y, Suhaimi FH. et al. Animal models of metabolic syndrome: a review. Nutr Metab. 2016;13:65-65
57. Gregersen S, Samocha-Bonet D, Heilbronn LK. et al. Inflammatory and oxidative stress responses to high-carbohydrate and high-fat meals in healthy humans. J Nutr Metab. 2012;2012:238056-238056
58. Chou C-L, Lin H, Chen J-S. et al. Renin inhibition improves metabolic syndrome, and reduces angiotensin II levels and oxidative stress in visceral fat tissues in fructose-fed rats. PloS one. 2017;12:e0180712-e0180712
59. Roberts CK, Sindhu KK. Oxidative stress and metabolic syndrome. Life Sci. 2009;84:705-712
60. Puchau B, Zulet MA, de Echávarri AG. et al. Dietary total antioxidant capacity is negatively associated with some metabolic syndrome features in healthy young adults. Nutrition. 2010;26:534-541
61. Sharma P. Inflammation and the metabolic syndrome. Indian J Clin Biochem. 2011;26:317-318
62. Reddy P, Lent-Schochet D, Ramakrishnan N. et al. Metabolic syndrome is an inflammatory disorder: A conspiracy between adipose tissue and phagocytes. Clin Chim. 2019;496:35-44
63. Wong SK, Chin K-Y, Suhaimi FH. et al. The Relationship between Metabolic Syndrome and Osteoporosis: A Review. Nutrients. 2016;8:347
64. Marsland AL, McCaffery JM, Muldoon MF. et al. Systemic inflammation and the metabolic syndrome among middle-aged community volunteers. Metabolism. 2010;59:1801-8
65. Tsalamandris S, Antonopoulos AS, Oikonomou E. et al. The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives. Eur Cardiol. 2019;14:50-59
66. De Miguel C, Rudemiller NP, Abais JM. et al. Inflammation and hypertension: new understandings and potential therapeutic targets. Curr Hypertens Rep. 2015;17:507-507
67. Tall AR, Yvan-Charvet L. Cholesterol, inflammation and innate immunity. Nature reviews. Immunology. 2015;15:104-116
68. Sur G, Floca E, Kudor-Szabadi L. et al. The relevance of inflammatory markers in metabolic syndrome. Maedica. 2014;9:15-18
69. Furukawa S, Fujita T, Shimabukuro M. et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114:1752-1761
70. Wong SK, Chin K-Y, Ima-Nirwana S. Toll-like Receptor as a Molecular Link between Metabolic Syndrome and Inflammation: A Review. Curr Drug Targets. 2019;20:1264-1280
71. Jialal I, Huet BA, Kaur H. et al. Increased toll-like receptor activity in patients with metabolic syndrome. Diabetes Care. 2012;35:900-904
72. Jialal I, Rajamani U, Adams-Huet B. et al. Circulating pathogen-associated molecular pattern - binding proteins and High Mobility Group Box protein 1 in nascent metabolic syndrome: implications for cellular Toll-like receptor activity. Atherosclerosis. 2014;236:182-187
73. Padayatty SJ, Levine M. Vitamin C: the known and the unknown and Goldilocks. Oral Dis. 2016;22:463-493
74. Hoppel C. The role of carnitine in normal and altered fatty acid metabolism. Am J Kidney Dis. 2003;41:S4-12
75. Johnston CS, Corte C, Swan PD. Marginal vitamin C status is associated with reduced fat oxidation during submaximal exercise in young adults. Nutr Metab. 2006;3:35-35
76. Norouzirad R, Gonzalez-Muniesa P, Ghasemi A. Hypoxia in Obesity and Diabetes: Potential Therapeutic Effects of Hyperoxia and Nitrate. Oxid Med Cell Longev. 2017;2017:5350267
77. Robey IF, Lien AD, Welsh SJ. et al. Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors. Neoplasia. 2005;7:324-330
78. Pawlowska E, Szczepanska J, Blasiak J. Pro- and Antioxidant Effects of Vitamin C in Cancer in correspondence to Its Dietary and Pharmacological Concentrations. Oxid Med Cell Longev. 2019;2019:7286737
79. Carr AC, Lykkesfeldt J. Discrepancies in global vitamin C recommendations: a review of RDA criteria and underlying health perspectives. Crit Rev Food Sci Nutr. 2020 p: 1-14
80. Carr AC, Pullar JM, Bozonet SM. et al. Marginal Ascorbate Status (Hypovitaminosis C) Results in an Attenuated Response to Vitamin C Supplementation. Nutrients. 2016 8
81. Jungert A, Neuhäuser-Berthold M. The lower vitamin C plasma concentrations in elderly men compared with elderly women can partly be attributed to a volumetric dilution effect due to differences in fat-free mass. Br J Nutr. 2015;113:859-64
82. Langlois K, Cooper M, Colapinto CK. Vitamin C status of Canadian adults: Findings from the 2012/2013 Canadian Health Measures Survey. Health Rep. 2016;27:3-10
83. Frei B, Trabe MG. The new US Dietary Reference Intakes for vitamins C and E. Redox Rep. 2001;6:5-9
84. Gabbay KH, Bohren KM, Morello R. et al. Ascorbate synthesis pathway: dual role of ascorbate in bone homeostasis. J Biol Chem. 2010;285:19510-20
85. Padayatty SJ, Sun H, Wang Y. et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004;140:533-7
Corresponding author: Prof. Dr. Ima-Nirwana Soelaiman, Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaakob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia. Tel: +603-9145 9579 Fax: +603-9145 9547 Email: imasoelukm.edu.my